new glp 1 agonist for weight loss GLP-1 Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Study finds GLP-1 receptor agonists
Description
They can also be used to prevent and treat endocrine disorders or metabolic diseases such as polycystic ovary syndrome (PCOS), obesity, and non-alcoholic fatty liver disease (NAFLD) (135)
For more information, visit www.nclnet.org.
Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)
Association of American Medical Colleges
GLP-1 Receptor Agonists Genotype Report: Access this content: An active subscription is required to access this content
Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, et al
